Research Interests
Epigenetics and epitranscriptomics, Post-transcription regulation, Cell signaling, Metabolism, DNA damage repair


Dr. Anirban Kundu earned his Ph.D. from Indian Institute of Technology Kharagpur (IIT-Kgp) India. He joined the Department of Urology as a postdoctoral trainee in 2016. He has been studying the biology of kidney cancer (RCC). The study encompasses epigenetics, metabolomics, and signal transduction. He has been using various bioinformatics tools, in vitro and in vivo (mouse) model systems to identify and intervene in druggable axes in kidney cancer. Dr. Kundu’s research goal is to find metabolic and signaling liabilities in kidney cancer that can be targeted with utmost potency using mono-or-combination therapies.

Education and Degrees

Indian Institute of Technology Kharagpur, Ph.D. 

Postdoctoral Training
The University of Alabama at Birmingham  

Contact Information

420 WTI